(3-Bromopyridin-4-yl)carbamic acid tert-butyl ester, 95.0%, 1g

1-(Trifluoromethyl)-3-vinylbenzene, 95.0%, 25g

4-Bromo-2-chloro-5-fluorophenol, 97%, 250mg

1,3,5-Pentanetricarboxylic Acid, 98.0%, 5g

2,3-Dichloro-6-methylquinoxaline, 95.0%, 5g

1-methyl-4,5,6,7-tetrahydro-1H-benzimidazole, 95.0%, 5g

1-(2-bromophenyl)-6-chloro-1-oxohexane, 97.0%, 1g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline>98.0%(GC)5g

2-[[[(Tetrahydro-2-furanyl)methyl]amino]methyl]phenol, 98%, 250mg

Ethyl 4-hydroxypiperidine-1-carboxylate, 98.0%, 25g

tert-Butyl ((1-(cyanomethyl)cyclohexyl)methyl)carbamate, 97%, 50mg

N,N-diméthylcyclohexylamine, min 99%, pour synthèse, 2,5 L, emballage verre

2-PHENYLCYCLOBUTANONE, 95.0%, 1g